Gabriele Neumann
Overview
Explore the profile of Gabriele Neumann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
8120
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Imai M, Ueki H, Ito M, Iwatsuki-Horimoto K, Kiso M, Biswas A, et al.
Emerg Microbes Infect
. 2025 Jan;
14(1):2450029.
PMID: 39781889
Since early 2024, highly pathogenic avian influenza H5N1 viruses have been causing outbreaks in dairy cattle in the United States. Here, we compared the replicative capacity of A/dairy cattle/Texas/24-008749-001/2024 (H5N1;...
2.
Gu C, Babujee L, Pattinson D, Chiba S, Jester P, Maemura T, et al.
NPJ Vaccines
. 2025 Jan;
10(1):2.
PMID: 39774170
Influenza B viruses pose a significant threat to global public health, leading to severe respiratory infections in humans and, in some cases, death. During the last 50 years, influenza B...
3.
Gu C, Maemura T, Guan L, Eisfeld A, Biswas A, Kiso M, et al.
Nature
. 2024 Oct;
636(8043):711-718.
PMID: 39467571
The outbreak of clade 2.3.4.4b highly pathogenic avian influenza viruses of the H5N1 subtype (HPAI H5N1) in dairy cattle in the USA has so far resulted in spillover infections of...
4.
Yamaji R, Zhang W, Kamata A, Adlhoch C, Swayne D, Pereyaslov D, et al.
Lancet Microbe
. 2024 Oct;
6(3):100973.
PMID: 39396528
A systematic risk assessment approach is essential for evaluating the relative risk of influenza A viruses (IAVs) with pandemic potential. To achieve this, the Tool for Influenza Pandemic Risk Assessment...
5.
Hoxie I, Vasilev K, Clark J, Bushfield K, Francis B, Loganathan M, et al.
Vaccine
. 2024 Sep;
42(24):126269.
PMID: 39241354
Recombinant influenza virus neuraminidase (NA) is a promising broadly protective influenza vaccine candidate. However, the recombinant protein alone is not sufficient to induce durable and protective immune responses and requires...
6.
Neumann G, Kawaoka Y
Nat Rev Microbiol
. 2024 Jul;
22(9):525-526.
PMID: 39060613
No abstract available.
7.
Eiden J, Fierro C, White A, Davis M, Rhee M, Turner M, et al.
Lancet Infect Dis
. 2024 Jul;
24(10):1118-1129.
PMID: 39004096
Background: Older adults (aged ≥65 years) show increased susceptibility to severe disease with influenza virus infection, accounting for 70-85% of annual influenza-related fatalities in the USA. Stimulating mucosal antibodies and...
8.
Eisfeld A, Biswas A, Guan L, Gu C, Maemura T, Trifkovic S, et al.
Nature
. 2024 Jul;
633(8029):426-432.
PMID: 38977017
Highly pathogenic H5N1 avian influenza (HPAI H5N1) viruses occasionally infect, but typically do not transmit, in mammals. In the spring of 2024, an unprecedented outbreak of HPAI H5N1 in bovine...
9.
Petrie J, Pattinson D, King J, Neumann G, Guan L, Jester P, et al.
Am J Epidemiol
. 2024 Jun;
PMID: 38885957
Studies of SARS-CoV-2 incidence are important for response to continued transmission and future pandemics. We followed a rural community cohort with broad age representation with active surveillance for SARS-CoV-2 identification...
10.
Rahe-Meyer N, Neumann G, Schmidt D, Downey L
Clin Appl Thromb Hemost
. 2024 May;
30:10760296241254106.
PMID: 38803191
Fibrinogen concentrate treatment is recommended for acute bleeding episodes in adult and pediatric patients with congenital and acquired fibrinogen deficiency. Previous studies have reported a low risk of thromboembolic events...